{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:16:29Z","timestamp":1787613389727,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The study aims to evaluate the effectiveness of local injection of autologous platelet rich plasma (A-PRP) as a treatment for women suffering from stress urinary incontinence (SUI). In a prospective intervention study, twenty consecutive women suffering from SUI were treated with A-PRP injection at anterior vaginal wall where mid-urethra locates. Self-reported questionnaires were used to measure pre-treatment, 1\u00a0month and 6\u00a0months post-treatment symptom severity. Secondary outcomes of sexual function and treatment effect sorted by age were analyzed with valid statistical methods. A-PRP is effective in relieving SUI symptoms at both 1\u00a0month and 6\u00a0months post-treatment without significant adverse reactions reported. It seems to have a trend that treatment success rate with cured and improved symptoms was slightly higher in the younger group, although it did not reach statistical significance (<jats:italic>P<\/jats:italic>\u2009=\u20090.07). No significant changes in sexual function before and after the treatment were reported by the patients. This pilot study is the first to report A-PRP treatment effect for SUI in women. The result suggested that A-PRP is a considerable treatment option for mild to moderate SUI cases. It also opens up further research opportunities for A-PRP\u2019s clinical applications.<\/jats:p>","DOI":"10.1038\/s41598-020-80598-2","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:02:30Z","timestamp":1610708550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["A pilot study: effectiveness of local injection of autologous platelet-rich plasma in treating women with stress urinary incontinence"],"prefix":"10.1038","volume":"11","author":[{"given":"Cheng-Yu","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Ru","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Ru","family":"Ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Xi","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"80598_CR1","doi-asserted-by":"publisher","unstructured":"Andia, E., Rubio-Azpeitia, J., Martin, I. & Abate, M: Current concepts and translational uses of platelet rich plasma biotechnology. In Biotechnology (ed. Ekinci, D.) (InTech, 2015). https:\/\/doi.org\/10.5772\/59954. https:\/\/www.intechopen.com\/books\/biotechnology\/current-concepts-and-translational-uses-of-plateletrich-plasma-biotechnology.","DOI":"10.5772\/59954"},{"key":"80598_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000477353","volume":"4","author":"R Alves","year":"2018","unstructured":"Alves, R. & Grimalt, R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage disord. 4, 18\u201324. https:\/\/doi.org\/10.1159\/000477353 (2018).","journal-title":"Skin Appendage disord."},{"key":"80598_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.32098\/mltj.03.2014.18","volume":"4","author":"A Guevara-Alvarez","year":"2014","unstructured":"Guevara-Alvarez, A., Schmitt, A., Russell, R. P., Imhoff, A. B. & Buchmann, S. Growth factor delivery vehicles for tendon injuries: mesenchymal stem cells and platelet rich plasma. Muscles Ligaments Tendons J. 4, 378\u2013385 (2014).","journal-title":"Muscles Ligaments Tendons J."},{"key":"80598_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4111\/icu.2018.59.1.61","volume":"59","author":"EL Matz","year":"2018","unstructured":"Matz, E. L., Pearlman, A. M. & Terlecki, R. P. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig. Clin. Urol. 59, 61\u201365. https:\/\/doi.org\/10.4111\/icu.2018.59.1.61 (2018).","journal-title":"Investig. Clin. Urol."},{"key":"80598_CR5","doi-asserted-by":"publisher","first-page":"CD012314","DOI":"10.1002\/14651858.CD012314.pub2","volume":"3","author":"T Moutray","year":"2018","unstructured":"Moutray, T. et al. Different lasers and techniques for proliferative diabetic retinopathy. Cochrane Database Syst. Rev. 3, CD012314. https:\/\/doi.org\/10.1002\/14651858.CD012314.pub2 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"80598_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jmig.2007.05.014","volume":"14","author":"J Fanning","year":"2007","unstructured":"Fanning, J. et al. Phase I\/II prospective trial of autologous platelet tissue graft in gynecologic surgery. J. Min. Invas. Gynecol. 14, 633\u2013637. https:\/\/doi.org\/10.1016\/j.jmig.2007.05.014 (2007).","journal-title":"J. Min. Invas. Gynecol."},{"key":"80598_CR7","unstructured":"Hunskaar, S., Burigio, K., Diokno, A. C., Herzog, A. R., Hjalmas, K. & Lapitan, M. C. Epidemiology and natural history of urinary incontinence. In Incontinence: 2nd International Consultation on Incontinence. Recommendations of the International Scientific Committee: The Evaluation and Treatment of Urinary Incontinence. Paris, 1\u20133 July 2001 (ed. Abrams, P., Cardozo, L., Khoury, S. & Wein, A.) Medline: 20304 (Health Publication Ltd, Plymouth, UK, 2002)."},{"key":"80598_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/spv.0000000000000173","volume":"21","author":"CM Kunkle","year":"2015","unstructured":"Kunkle, C. M. et al. Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence. Female Pelvic Med. Reconstr. Surg. 21, 154\u2013159. https:\/\/doi.org\/10.1097\/spv.0000000000000173 (2015).","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"80598_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.maturitas.2017.12.008","volume":"109","author":"G Capobianco","year":"2018","unstructured":"Capobianco, G. et al. Management of female stress urinary incontinence: a care pathway and update. Maturitas 109, 32\u201338. https:\/\/doi.org\/10.1016\/j.maturitas.2017.12.008 (2018).","journal-title":"Maturitas"},{"key":"80598_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0412.1990.tb08027.x","volume":"153","author":"PE Petros","year":"1990","unstructured":"Petros, P. E. & Ulmsten, U. I. An integral theory of female urinary incontinence, experimental and clinical considerations. Acta Obstet. Gynecol. Scand. Suppl. 153, 7\u201331 (1990).","journal-title":"Acta Obstet. Gynecol. Scand. Suppl."},{"key":"80598_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mehy.2016.02.019","volume":"90","author":"KI Nikolopoulos","year":"2016","unstructured":"Nikolopoulos, K. I., Pergialiotis, V., Perrea, D. & Doumouchtsis, S. K. Restoration of the pubourethral ligament with platelet rich plasma for the treatment of stress urinary incontinence. Med. Hypotheses 90, 29\u201331. https:\/\/doi.org\/10.1016\/j.mehy.2016.02.019 (2016).","journal-title":"Med. Hypotheses"},{"key":"80598_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4172\/2167-0420.1000169","volume":"3","author":"C Runels","year":"2014","unstructured":"Runels, C., Melnick, H., Debourbon, E. & Roy, L. A pilot study of the effect of localized injections of autologous platelet rich plasma (PRP) for the treatment of female sexual dysfunction. J. Women\u2019s Health Care 3, 169 (2014).","journal-title":"J. Women\u2019s Health Care"},{"key":"80598_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijgo.2012.05.029","volume":"119","author":"X Hua","year":"2012","unstructured":"Hua, X. et al. Using platelet-rich plasma for the treatment of symptomatic cervical ectopy. Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet. 119, 26\u201329. https:\/\/doi.org\/10.1016\/j.ijgo.2012.05.029 (2012).","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet."},{"key":"80598_CR14","doi-asserted-by":"publisher","first-page":"e1124","DOI":"10.1097\/gox.0000000000001124","volume":"4","author":"F Behnia-Willison","year":"2016","unstructured":"Behnia-Willison, F. et al. Use of platelet-rich plasma for vulvovaginal autoimmune conditions like lichen sclerosus. Plast. Reconstr. Surg. Glob. Open 4, e1124. https:\/\/doi.org\/10.1097\/gox.0000000000001124 (2016).","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"80598_CR15","doi-asserted-by":"publisher","first-page":"e0171554","DOI":"10.1371\/journal.pone.0171554","volume":"12","author":"B Bodner-Adler","year":"2017","unstructured":"Bodner-Adler, B., Hanzal, E., Pablik, E., Koelbl, H. & Bodner, K. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: a systematic review and meta-analysis. PLoS ONE 12, e0171554. https:\/\/doi.org\/10.1371\/journal.pone.0171554 (2017).","journal-title":"PLoS ONE"},{"key":"80598_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mehy.2017.05.018","volume":"104","author":"EL Chrysanthopoulou","year":"2017","unstructured":"Chrysanthopoulou, E. L. et al. Platelet rich plasma as a minimally invasive approach to uterine prolapse. Med. Hypotheses 104, 97\u2013100. https:\/\/doi.org\/10.1016\/j.mehy.2017.05.018 (2017).","journal-title":"Med. Hypotheses"},{"key":"80598_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jmig.2008.12.012","volume":"16","author":"JI Einarsson","year":"2009","unstructured":"Einarsson, J. I., Jonsdottir, K. & Mandle, R. Use of autologous platelet gel in female pelvic organ prolapse surgery: a feasibility study. J. Min. Invas. Gynecol. 16, 204\u2013207. https:\/\/doi.org\/10.1016\/j.jmig.2008.12.012 (2009).","journal-title":"J. Min. Invas. Gynecol."},{"key":"80598_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nm.2669","volume":"18","author":"YA White","year":"2012","unstructured":"White, Y. A. et al. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat. Med. 18, 413\u2013421. https:\/\/doi.org\/10.1038\/nm.2669 (2012).","journal-title":"Nat. Med."},{"key":"80598_CR19","first-page":"179","volume":"31","author":"GVL Colombo","year":"2017","unstructured":"Colombo, G. V. L. et al. Use of platelet rich plasma in human infertility. J. Biol. Regul. Homeost. Agents 31, 179\u2013182 (2017).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"80598_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/pd.2249","volume":"29","author":"L Lewi","year":"2009","unstructured":"Lewi, L. et al. In vitro evaluation of the ability of platelet-rich plasma to seal an iatrogenic fetal membrane defect. Prenat. Diagn. 29, 620\u2013625. https:\/\/doi.org\/10.1002\/pd.2249 (2009).","journal-title":"Prenat. Diagn."},{"key":"80598_CR21","doi-asserted-by":"publisher","first-page":"e34449","DOI":"10.5812\/ircmj.34449","volume":"18","author":"A Tehranian","year":"2016","unstructured":"Tehranian, A. et al. Application of autologous platelet-rich plasma (PRP) on wound healing after caesarean section in high-risk patients. Iran. Red Crescent Med. J. 18, e34449. https:\/\/doi.org\/10.5812\/ircmj.34449 (2016).","journal-title":"Iran. Red Crescent Med. J."},{"key":"80598_CR22","first-page":"7915813","volume":"15","author":"KL Lin","year":"2019","unstructured":"Lin, K. L., Chou, S. H. & Long, C. Y. Effect of Er:YAG laser for women with stress urinary incontinence. Biomed. Res. Int. 15, 7915813 (2019).","journal-title":"Biomed. Res. Int."},{"key":"80598_CR23","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.eurox.2019.100099","volume":"5","author":"F Behnia-Willison","year":"2019","unstructured":"Behnia-Willison, F. et al. Promising impact of platelet rich plasma and carbon dioxide laser for stress urinary incontinence. Eur. J. Obstet. Gynecol. Reprod. Biol. X 5, 100099 (2019).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X"},{"key":"80598_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/nau.20674","volume":"28","author":"A Klovning","year":"2009","unstructured":"Klovning, A., Avery, K., Sandvik, H. & Hunskaar, S. Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol. Urodyn. 28, 411\u2013415. https:\/\/doi.org\/10.1002\/nau.20674 (2009).","journal-title":"Neurourol. Urodyn."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80598-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:11:32Z","timestamp":1670033492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80598-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80598"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80598-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"1 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1584"}}